1.
Clin Infect Dis
; 2022 Jun 14.
Article
in English
| MEDLINE | ID: covidwho-2234739
ABSTRACT
In a cohort of 483 high-risk patients treated with nirmatrelvir/ritonavir for coronavirus disease-2019, two patients (0.4%) required hospitalization by day 30. Four patients (0.8%) experienced rebound of symptoms, which were generally mild, at median of 9 days after treatment, and all resolved without additional COVID-19-directed therapy.